Biocon Biologics agreed to a settlement-and-license agreement with Amgen that will permit it to market drugs in the United States that are biosimilars to Amgen's Prolia and Xgeva. Both medications use ...
Amgen Inc. (NASDAQ:AMGN) is one of the Best Wide Moat Stocks to Buy Right Now. The company possesses a wide economic moat, ...
U.S. Food and Drug Administration (FDA) has approved expanded indications for YUFLYMA® (adalimumab-aaty) and its unbranded version, to include the treatment of hidradenitis suppurativa (HS) in ...
A new study shows glioblastoma isn’t confined to the brain—it erodes the skull and hijacks the immune system within skull ...
Glioblastoma, the most lethal brain cancer, doesn’t just damage the brain—it erodes the skull and disrupts the immune system by reshaping marrow inside the skull.
Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects ...
To find out, they gave mice with glioblastoma tumors two different drugs approved by the U.S. Food and Drug Administration for treating osteoporosis. Both drugs (zoledronic acid and denosumab) halted ...
Vietnam Investment Review on MSN
Biosimilars innovation to transform Vietnamese pharma
On his first business trip to Vietnam, Russell Miller, vice president of Global Sales and Marketing at Enzene Biosciences, shared with VIR’s Ho Ha the company’s ambition to reshape the global ...
Using single-cell RNA sequencing, the researchers found that glioblastoma had dramatically shifted the skull marrow's immune-cell balance in favor of pro-inflammatory myeloid cells—nearly doubling the ...
The approval was based on a comprehensive clinical data package that included a phase 3 trial comparing denosumab-qbde with Prolia in 473 women with postmenopausal osteoporosis.
Alvotech’s biosimilar strategy, strong partnerships, and global launches may offer compelling biotech investment potential in ...
A federal judge blocked the Trump administration on Tuesday from permanently steering $233 million in FEMA disaster relief funds away from 12 blue states, issuing a restraining order just hours before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results